ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Significant differences in EPA content in liver and three adipose tissues depots (Table 2) may also lead to increase of adiponectin secretion in adipose area [57], that could increase the risk of comorbidities of obesity, including cardiovascular disease and insulin resistance [58].